Cancer Research and Treatment10.4143/crt.2020.135020215341033-1041Prognostic Factor and Clinical Outcome in Stage III Non-Small Cell Lung Cancer: A Study Based on Real-World Clinical Data in the Korean PopulationHo Cheol Kim, Wonjun Ji, Jae Cheol Lee, Hyeong Ryul Kim, Si Yeol Song, Chang-Min Choi, ,,,
Lung Cancer10.1016/s0169-5002(20)30143-42020139S51Real-world data of using durvalumab in stage III non-small cell lung cancer (NSCLC): West Midlands experienceA. Jegannathen,
Clinical Lung Cancer10.1016/j.cllc.2023.02.0092023243252-259Tumor Volume Is a Better Prognostic Factor than Greatest Tumor Diameter in Operated Stage I-III Non–Small-Cell Lung CancerAyşe Ocak Duran, Mevlude Inanc, Oktay Bozkurt, Ersin Ozaslan, Metin Ozkan,
Clinical Lung Cancer10.1016/j.cllc.2012.06.00520131411-5Improving Outcomes for High-Risk Patients With Early-Stage Non–Small-Cell Lung Cancer: Insights from Population-Based Data and the Role of Stereotactic Ablative RadiotherapyDavid A. Palma, Suresh Senan,
Clinical Lung Cancer10.3816/clc.2007.n.031200788478-482Prognostic Factors in Stage III Non–Small-Cell Lung CancerFoluso O. Ademuyiwa, Cynthia S. Johnson, Angela S. White, Timothy E. Breen, Jayme Harvey, Marcus Neubauer, Nasser H. Hanna,
Clinical Lung Cancer10.1016/s1525-7304(11)70694-5200674276-278Prophylactic Cranial Irradiation Versus Observation in Stage III Non–Small-Cell Lung CancerElizabeth Gore,
Clinical Lung Cancer10.1016/s1525-7304(11)70793-819991168-69Commentary on “Prognostic Markers in Resected Stage I and II Non–Small-Cell Lung Cancer Patients”David H. Harpole,
Clinical Lung Cancer10.1016/j.cllc.2022.02.0022022234364-373Real-world Treatment Patterns and Outcomes in Stage III Non-small Cell Lung Cancer: Middle East and Africa – KINDLE StudyA.R. Jazieh, E. Kaytan Sağlam, H.C. Önal, Y. Abdelkader, R. Gaafar, E. Dawoud, M. Nassar, D. Alshorbagy, H. El Ashry, M. Elsayed,
Clinical Lung Cancer10.3816/clc.2002.s.01820024S21-S25Irinotecan Combined with Radiation Therapy for Patients with Stage III Non—Small-Cell Lung Cancer: Current TrialsNagahiro Saijo,
Clinical Oncology10.1016/j.clon.2016.04.04520162810639-647Application of Guideline Recommended Treatment in Routine Clinical Practice: A Population-based Study of Stage I–IIIB Non-small Cell Lung CancerK.J. Duggan, J. Descallar, S.K. Vinod,